Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin

被引：5
|
作者：
Matthews, Annette M.
Fireman, Marian
Zucker, Betsy
Sobel, Michelle
Hauser, Peter
机构：
[1] Portland VA Med Ctr, NW Hepatitis Resource Ctr C, JENS Lab, Gastroenterol Sect, Portland, OR 97202 USA
[2] Portland VA Med Ctr, Behav Hlth & Clin Neurosci Div, Portland, OR 97202 USA
[3] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97202 USA
[4] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97202 USA
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2006年 / 163卷 / 08期
关键词：
D O I：
10.1176/appi.ajp.163.8.1342
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：1342 / 1347
页数：6
相关论文
共 50 条
  • [21] Chronic hepatitis C: Retreatment of pegylated interferon/ribavirin nonresponders
    Cardoso, Helder
    Vale, Ana Horta
    Mendes, Margarida
    Bastos, Pedro
    Machado, Artur
    Santos, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S192 - S193
  • [22] Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
    Cho, Hyun Chin
    Gwak, Geum-Youn
    Paik, Yong Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Yoo, Byung Chul
    Paik, Seung Woon
    GUT AND LIVER, 2013, 7 (05) : 585 - 593
  • [23] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Rosen, Irit
    Kori, Michal
    Adiv, Orly Eshach
    Yerushalmi, Baruch
    Zion, Nataly
    Shaoul, Ron
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1098 - 1103
  • [24] Retreatment of Chronic Hepatitis C with Interferon Alfacon-1/Ribavirin after Nonresponse to Pegylated Interferon/Ribavirin in Veterans
    Patel, Nehali
    Suman, Amitabh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S100 - S101
  • [25] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Yee, Helen S.
    Currie, Sue L.
    Tortorice, Kathryn
    Cozen, Myrna
    Shen, Hui
    Chapman, Summer
    Cunningham, Fran
    Monto, Alexander
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2439 - 2448
  • [26] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Helen S. Yee
    Sue L. Currie
    Kathryn Tortorice
    Myrna Cozen
    Hui Shen
    Summer Chapman
    Fran Cunningham
    Alexander Monto
    Digestive Diseases and Sciences, 2011, 56 : 2439 - 2448
  • [27] Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis C
    Kowala-Piaskowska, Arleta
    Mozer-Lisewska, Iwona
    Figlerowicz, Magdalena
    Sluzewski, Wojciech
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (10) : 1095 - 1103
  • [28] Treatment response of chronic hepatitis C virus infection with pegylated-interferon and ribavirin
    Humphris, J. L.
    Ngu, M. C.
    Lee, A. U.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A331 - A331
  • [29] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [30] Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C
    Durante-Mangoni, E.
    Ragone, E.
    Pinto, D.
    Iossa, D.
    Covino, F. E.
    Maiello, C.
    Utili, R.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (01) : 299 - 303
12345